VOLPICELLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 625
EU - Europa 450
AS - Asia 205
AF - Africa 14
SA - Sud America 2
Totale 1.296
Nazione #
US - Stati Uniti d'America 615
IT - Italia 267
SG - Singapore 123
SE - Svezia 48
IN - India 33
FI - Finlandia 26
DE - Germania 25
CN - Cina 23
AT - Austria 16
ID - Indonesia 16
TG - Togo 12
FR - Francia 11
BG - Bulgaria 10
CA - Canada 9
RO - Romania 8
IE - Irlanda 7
NL - Olanda 5
RU - Federazione Russa 5
BE - Belgio 4
CH - Svizzera 4
KR - Corea 3
UA - Ucraina 3
GB - Regno Unito 2
MK - Macedonia 2
MY - Malesia 2
RS - Serbia 2
AM - Armenia 1
AR - Argentina 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
TR - Turchia 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 1.296
Città #
Singapore 99
Rome 81
Chandler 73
Fairfield 73
Ashburn 41
Houston 38
Woodbridge 34
Santa Clara 31
Wilmington 26
Milan 25
Seattle 24
Helsinki 22
San Paolo di Civitate 21
Jakarta 16
Ann Arbor 14
Cambridge 14
Princeton 14
Vienna 14
Fremont 13
Lawrence 13
Lomé 12
Millbury 12
New York 12
San Diego 12
Beijing 11
Bremen 11
Sofia 10
Naples 9
Dublin 7
San Mateo 7
Boardman 6
Buffalo 6
Florence 6
Andover 4
Boston 4
Catania 4
Induno Olona 4
Baie-D'Urfe 3
Bari 3
Barrie 3
Bern 3
Lappeenranta 3
Los Angeles 3
Norwalk 3
Plano 3
Verona 3
Amsterdam 2
Aosta 2
Atlanta 2
Belgrade 2
Brussels 2
Castel Madama 2
Dallas 2
Falkenstein 2
Foggia 2
Grosse Pointe 2
Hangzhou 2
Leuven 2
Lingolsheim 2
Lyon 2
Mannheim 2
Moscow 2
Nepi 2
Phoenix 2
Romainville 2
Romola 2
Stockholm 2
Toronto 2
Turin 2
Varese 2
Altofonte 1
Azor 1
Berlin 1
Budapest 1
Bühl 1
Carbonara al Ticino 1
Clifton 1
Dearborn 1
Des Moines 1
Federal 1
Frankfurt am Main 1
Fuzhou 1
Gazzo 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Hounslow 1
Jacksonville 1
Jiaxing 1
Leander 1
Lincoln 1
Livorno 1
Massa 1
Melzo 1
Montréal 1
Muizenberg 1
Munich 1
Nanjing 1
Novara 1
Pofi 1
Totale 928
Nome #
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 105
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin 103
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major 101
Vitamin D deficiency and health-related quality of life in chronic hepatitis C 100
Encephalopathy in a patient with loiasis treated with albendazole: a case report 100
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside 93
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV child-A cirrhosis 75
HCV cirrhotic patients treated with direct acting antivirals: detection of tubular dysfunction and resolution after viral clearance 67
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants 63
Glecaprevir/pibrentasvir ultra-short treatment to cure HCV infection: case report and literature review 62
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV Child-A cirrhosis 55
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in hepatitis C virus child-A cirrhosis 52
Are Follow-Up Blood Cultures useful in the antimicrobial management of gram negative bacteremia? A reappraisal of their role based on current knowledge 50
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations 49
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization 47
Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design 39
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study 31
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience 29
The role of combination therapy in critically Ill patients with methicillin-susceptible staphylococcus aureus bloodstream infections. Does the question remain? 26
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study 25
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study 17
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 15
A role for ceftazidime/avibactam combination therapy. The question may still be on the table 14
Risk of Seven-Day Worsening and Death: A New Clinically Derived COVID-19 Score 13
New antimicrobials and new therapy strategies for endocarditis. Weapons that should be defended 13
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study 12
Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis? 11
Place in therapy of the newly available armamentarium for multi-drug-resistant gram-negative pathogens. Proposal of a prescription agorithm 11
null 10
Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin 9
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin 7
Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing K. pneumoniae bloodstream infection: a retrospective cohort study 7
null 3
Totale 1.414
Categoria #
all - tutte 5.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020151 0 0 0 0 0 24 32 22 20 33 15 5
2020/2021108 8 6 3 2 7 14 3 11 32 6 12 4
2021/2022234 16 26 19 15 22 8 10 21 8 6 52 31
2022/2023325 33 72 34 46 47 30 6 16 21 2 8 10
2023/2024245 8 20 10 15 22 55 8 17 12 33 24 21
2024/2025285 12 46 41 77 37 72 0 0 0 0 0 0
Totale 1.414